Germany· DE-A57-82e048d9b016f9fc
Allergodil Nasenspray
A azelastine product containing azelastine hydrochloride, registered in Germany by Cooper Consumer Health Deutschland Gmbh. The same ATC class is registered in 11 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Azelastine is registered in 11 of 19 countries.
Countries holding a registration under ATC R01AC03 (azelastine), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 7 of them publish a price we can compare per daily dose
Azelastine · ATC R01AC03
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Azelastine Hydrochloride
- Manufacturer
- Cooper Consumer Health Deutschland Gmbh
- Country
- Germany (DE)
- ATC code
- R01AC03
- ATC class
- Azelastine
- Defined daily dose
- 0.56 mg, N
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
201 interactions on record for azelastine.
Graded by severity as the source publishes them — 200 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Azelastine · interactions on record
201 records
- 200 moderate
- 1 minor
Most severe, free to view
- MetoclopramideA03FA01moderate
- DiphenhydraminA04AB05moderate
- TriflupromazinA04AD06moderate
- NabiloneA04AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Azelastine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAstepro AllergyBayer HealthCare LLC.
- CzechiaALLERGODILVIATRIS HEALTHCARE LIMITED, Dublin
- United KingdomAller-Eze 0.05% eye dropsNovartis Consumer Health UK Ltd
- PolandAcatar AllergyUS Pharmacia Sp. z o.o.
- SpainAFLUON 0,5 mg/ml COLIRIO EN SOLUCIONCooper Consumer Health B.V.
- BelgiumAllergodil 0.05 %PI Pharma
- NetherlandsAllergodil Nevel, neusspray, oplossing 1 mg/mlEuro Registratie Collectief B.V.
- IrelandAstepro 1.5 mg/ml nasal spray, solutionCooper Consumer Health B.V.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Allergodil, Allergospray
- Belgium · Allergodil, Azelergo
- Bulgaria · Алергодил, Анталерг
- Czechia · Allergodil, Allergodil Forte
- Denmark · Allergodil, Allergodil Forte
- Estonia · Allergodil
- Spain · Afluon, Afluón
- Finland · Lastin
- France · Allergodil, Alonest
- United Kingdom (Northern Ireland) · Astepro, Azelair
- Greece · Afluon
- Croatia · Vivialle, Vivispray
- Hungary · Allergodil, Allergodil Forte
- Ireland · Astepro, Azelastine Eye Drops Mylan Ire Healthcare
- Iceland · Astepro, Lastin
- Italy · Allergodil, Allespray
- Lithuania · Allergodil
- Luxembourg · Allergodil, Azelergo
- Latvia · Allergodil
- Malta · Antalerg Unimed Pharma, Azelastin-Comod
- Netherlands · Allergodil, Allergodil Nevel
- Norway · Lastin
- Poland · Acatar Allergy, Allergodil
- Portugal · Allergodil, Astepro
- Romania · Allegodil, Allergodil
- Sweden · Azelastine Omnivision
- Slovenia · Alezaxin, Allergodil
- Slovakia · Allergodil, Antalerg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/905f0cbf-a43c-43f7-ba24-9e8317234621 GET /v1/drugs/905f0cbf-a43c-43f7-ba24-9e8317234621?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Nasal Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Azelastine Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about azelastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.